Site US10016

Durham, North Carolina 27710

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission
Status: Enrolling, Phase III
Updated: 12/31/1969
Site US10016
mi
from
Durham, NC
Click here to add this to my saved trials